Inhibrx Biosciences Inc. (INBX)

NASDAQ: INBX · Real-Time Price · USD

12.22

-0.11 (-0.89%)

At close: May 01, 2025, 3:59 PM

12.85

5.11%

Pre-market: May 02, 2025, 09:19 AM EDT

Inhibrx Biosciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	200K	1.8M	2.18M	7.13M	12.81M	9.09M	7.5M	7.95M	6.67M
Cost of Revenue	2.29M	1.19M	2.85M	2.69M	73.5M	47.91M	33.45M	25.51M	16.99M
Gross Profit	-2.08M	609K	-668K	4.44M	-60.69M	-38.81M	-25.95M	-17.56M	-10.32M
Operating Income	-331.45M	-219.22M	-129.12M	-76.56M	-67.44M	-43.71M	-29.51M	-19.73M	-12.15M
Interest Income	10.94M	11.92M	16.11M	5.22M	10.82M	5.72M	n/a	n/a	759K
Pretax Income	1.69B	-239.72M	-145.22M	-81.77M	-75.63M	-50.5M	-30.93M	-21.83M	-12.88M
Net Income	1.69B	-241.36M	-145.23M	-81.77M	-75.64M	-51.4M	-31.16M	-19.44M	-8.27M
Selling & General & Admin	127.91M	29.38M	21.12M	12.36M	6.84M	9.02M	4.65M	2.61M	1.57M
Research & Development	203.74M	190.65M	110.19M	71.44M	73.5M	47.91M	33.45M	25.51M	16.99M
Other Expenses	n/a	n/a	-14K	-106K	-80K	-4.12M	68K	24K	n/a
Operating Expenses	331.65M	219.83M	131.29M	83.69M	80.25M	52.81M	37.01M	27.68M	18.56M
Interest Expense	13.49M	31.84M	16.11M	5.22M	10.82M	5.72M	1.48M	2.13M	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-253K
Cost & Expenses	331.65M	221.02M	131.29M	83.69M	80.25M	52.81M	37.01M	27.68M	18.81M
Income Tax Expense	2K	3K	3K	2K	3K	898K	96K	250K	-4.62M
Shares Outstanding (Basic)	14.48M	47.13M	40.11M	38.01M	25.26M	36.55M	27.08M	28.79M	36.55M
Shares Outstanding (Diluted)	14.48M	47.13M	40.11M	38.01M	25.26M	36.55M	27.08M	28.79M	36.55M
EPS (Basic)	114.01	-5.12	-3.62	-2.15	-2.99	-1.41	-1.15	-0.68	-0.23
EPS (Diluted)	112.62	-5.12	-3.62	-2.15	-2.99	-1.41	-1.15	-0.68	-0.23
EBITDA	1.7B	-206.69M	-125.82M	-76.56M	-67.44M	-42.6M	-28.77M	-19.3M	-11.89M
EBIT	1.7B	-207.88M	-127.04M	-76.55M	-64.82M	-44.78M	-29.45M	-19.7M	n/a
Depreciation & Amortization	2.29M	1.19M	1.23M	2.69M	2.39M	2.52M	676K	399K	253K